HealthDay News — A way of life intervention is possible for sufferers with lymphoma present process chemotherapy, in line with a research offered on the annual assembly of the American Society of Hematology, held from Dec. 6 to 9 in Orlando, Florida.
Melissa Lopez-Pentecost, Ph.D., from the Sylvester Comprehensive Cancer Center on the University of Miami, and colleagues reported interim outcomes from the Lifestyle Intervention of Food and Exercise for Lymphoma Survivors (LIFE-L) trial involving adults with newly identified Hodgkin or non-Hodgkin lymphomas. Participants had been randomly assigned to a Mediterranean weight loss program and a home-based power and cardio train intervention, consisting of individualized weekly distant teaching classes with a dietitian and train physiologist all through chemotherapy, or a wait-list management group (44 and 28 sufferers, respectively).
The researchers discovered that the enrollment fee of eligible sufferers was excessive (81 %), and there was excessive intervention adherence, with attendance charges of 86 and 81 % for weight loss program classes and train classes, respectively, demonstrating feasibility. Compared with the management group, individuals within the intervention group reported decrease charges of moderate-to-very extreme signs, together with anxiousness, melancholy, ache, fatigue, and constipation on the postintervention time level. An analogous proportion of sufferers in every group reported moderate-to-severe shortness of breath. The intervention group had increased handgrip power, increased Short Physical Performance Battery (SPPB) scores, and better SPPB gait scores in contrast with the management group.
“Our goal with LIFE-L is to show that lifestyle interventions aren’t just for prevention or posttreatment — they can make a real difference during treatment,” co-lead writer Tracey Crane, Ph.D., additionally from the the Sylvester Comprehensive Cancer Center, mentioned in a press release.
Several authors disclosed ties to the biopharmaceutical business.